for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Top News

Breakingviews: Valeant lives up to its name

Posted

May 28 - Breakingviews columnists discuss why the Canadian pharmaceuticals company’s $8.7 bln deal for Bausch & Lomb is a reminder to other CEOs that being bold in M&A can sometimes pay.

Top News

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up